Logo

American Heart Association

  59
  0


Final ID: LB4

Endovascular treatment to improve outcomes for medium vessel occlusions: The ESCAPE-MeVO trial

Abstract Body: Rationale: Clinical outcomes in acute ischemic stroke due to medium vessel occlusion (MeVO) are often poor when treated with best medical management. Data from non-randomized studies suggest that endovascular treatment (EVT) may improve outcomes in MeVO stroke, but randomized data are hitherto lacking. Thus, there is insufficient evidence to guide endovascular treatment decision-making in MeVO stroke.
Aim: The primary aim of the ESCAPE-MeVO trial is to demonstrate that acute, rapid EVT in patients with acute ischemic stroke due to MeVO results in better clinical outcomes compared to best medical management. Secondary outcomes are to demonstrate the safety of EVT, its impact on self-reported health-related quality of life, and cost-effectiveness.
Sample size estimates: Based on previously published data, we estimate a sample size of 500 subjects to achieve a power of 85% with a two-sided alpha of 0.05. To account for potential loss to follow-up, a sample size of 530 subjects will be recruited.
Methods and design: ESCAPE-MeVO is a multicenter, prospective, randomized, open-label study with blinded endpoint evaluation (PROBE design), clinicaltrials.gov: NCT05151172. Subjects with acute ischemic stroke due to MeVO meeting the trial eligibility criteria will be allocated to best medical care plus EVT vs. best medical care only. Key eligibility criteria are 1) acute ischemic stroke due to MeVO that is clinically and technically eligible for EVT, 2) last-known well within the last 12 hours, 3) National Institutes of Health Stroke Scale >5 or 3-5 with disabling deficit, 4) high likelihood of salvageable tissue on non-invasive neuroimaging.
Study outcomes: The primary outcome is the modified Rankin scale 90 days after randomization (shift analysis), whereby modified Rankin Score 5 and 6 will be collapsed into one category. Secondary outcomes include dichotomizations of the modified Rankin Score at 90 days, 24-hour National Institutes of Health Stroke Score, difference between 24-hour and baseline National Institutes of Health Stroke Score, mortality at 90 days, self-reported health status, Lawton scale of instrumental activities of daily living score, reperfusion quality (MeVO expanded Thrombolysis in Cerebral Infarction Score) and infarct volume at 24 hours, and cost-effectiveness of endovascular recanalization. Safety outcomes include symptomatic and asymptomatic intracranial hemorrhage and procedural complications.
Results: Will be presented.
  • Goyal, Mayank  ( university of calgary , Calgary , Alberta , Canada )
  • Author Disclosures:
    Mayank Goyal: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Ownership Interest:Circle:Active (exists now) ; Research Funding (PI or named investigator):Cerenovus:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Advisor:Fluid Biomed:Active (exists now) ; Consultant:Mentice:Active (exists now) ; Consultant:Microvention:Active (exists now)
Meeting Info:
Session Info:

Opening Main Event

Wednesday, 02/05/2025 , 11:00AM - 12:35PM

ISC Invited Symposium

More abstracts on this topic:
Acute intracranial stenting among patients with large vessel occlusion: Clinical and radiological outcomes of the RESISTANT International registry

Requena Manuel, Lopez-frias Alfonso, Hassan Ameer, Miller Samantha, Zapata-arriaza Elena, De Alboniga-chindurza Asier, Bergui Mauro, Molinaro Stefano, Sousa Joao Andre, Gomes Fábio, Alexandre Andrea, Olive-gadea Marta, Pedicelli Alessandro, Hofmeister Jeremy, Machi Paolo, Scarcia Luca, Kalsoum Erwah, Meira Torcato, Amorim José, Ortega-gutierrez Santiago, Rodriguez Aaron, Capasso Francesco, Kaesmacher Johannes, Renieri Leonardo, Romano Daniele, Barcena Eduardo, Abdalkader Mohamad, Perry Da Camara Catarina, Yavagal Dileep, Vega Pedro, Ozdemir Atilla Ozcan, Smajda Stanislas, Khalife Jane, Mujanovic Adnan, Biraschi Francesco, Castro Pedro, Siddiqui Adnan, Navia Pedro, Ntoulias Nikolaos, Velo Mariano, Zamarro Joaquin, Zaidat Osama, Sierra-gomez Alicia, Marto Joao Pedro, Geyik Serdar, Tomasello Alejandro, Senadim Songul, Cervo Amedeo, Salcuni Andrea, Moreu Manuel

Achieving Fast Assessment and Stroke Triage in Kids (FAST-Kids)

Pearson Rachel, Hills Nancy, Bacon Kellie, Shelton Shelby, Moreno Tatiana, Kuchherzki Maria, Heyming Theodore, Schultz Carl, Fullerton Heather

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)